Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: E. coli O175:H7 strains used for antibacterial experiments.

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Isolation

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: Antibacterial activity of synthesized AgNPs at 1000 μg/mL concentrations in the water against E. coli O157:H7 strains ( A – I ).

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Activity Assay, Synthesized

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: Antibacterial efficacy of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains.

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Synthesized, Inhibition

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: Antibacterial activity of some commercial antibiotics against nine E. coli O157:H7 strains ( A – I ). Abbreviations: P (penicillin G, 10 μg/disc), E (erythromycin, 15 μg/disc), and VA (vancomycin, 30 μg/disc).

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Activity Assay

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: Antibacterial efficacy of some commercial antibiotics against E. coli O157:H7 strains—no inhibition zone.

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Inhibition

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: Growth curves of nine E. coli O157:H7 strains ( A – I ) cultured in LB broth with various concentrations of synthesized AgNPs to determine MIC. Control (●); 200 μg/mL (◦); 100 μg/mL (▼) 50 μg/mL (△); 25 μg/mL (§); 12.5 μg/mL (□); 6.25 μg/mL (w); 3.12 μg/mL (◊).

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Cell Culture, Synthesized, Control

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: MBC of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains ( A – I ).

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Synthesized

Journal: Polymers

Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

doi: 10.3390/polym14091834

Figure Lengend Snippet: FE-SEM images of normal E. coli O157:H7 (ATCC 35150) ( A , B ) and 1 × MBC probiotic-mediated synthesized AgNPs treated E. coli O157:H7 (ATCC 35150) ( C , D ).

Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

Techniques: Synthesized

Journal: Bacteriophage

Article Title: Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts

doi: 10.4161/bact.1.1.14175

Figure Lengend Snippet: Host range of bacteriophage CEV2

Article Snippet: Restriction enzyme digests of CEV2 have shown that its DNA is digested by Bam HI, Eco RI, Eco RV, Hae III, Hha I, Hin dIII, Pvu II, Sma I and Xho I like that of T5, forming similar fragments, and also like T5 it is not digested by McrBC ( ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 1 caption a7 Electron micrograph of bacteriophage CEV2. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 2 caption a7 Pulsed-field gel electrophoresis (PFGE) of undigested and restriction enzyme digested bacteriophage CEV2 DNA. (A) Lane A Sma I:CEV2; Lane B Ecor I:CEV2; Lane C Xho I:CEV2; Lane D TESC Lab Phage PFGE Ladder consisting of PEV3 [290 kb], T4 [175 kb], T5 [121.9 kb] and PEV2 [72.7 kb] and 816a [42.7 kb]; Lane E NEB Hind III:λ ladder [23.1, 9.4, 6.6, 4.4 kb]; Lane F undigested CEV2; Lane G Ecor V:CEV2; Lane H, Pvu II:CEV2; Lane I Hind III:CEV2. (B) Lane A Hha I:CEV2; Lane B Hae III:CEV2; Lane C McrBC:CEV2; Lane D BamH I:CEV2; Lane E TESC Lab Phage PFGE Ladder consisting of PEV3 [290 kb], T4 [175 kb], T5 [120 kb] and PEV2 [70 kb] and 816a [39 kb]; Lane F NEB Hind III:λ ladder [23.1, 9.4, 6.6, 4.4 kb]; Lane G undigested CEV2. table ft1 table-wrap mode="anchored" t5 caption a7 CEV2 sensitive strains CEV2 resistant strains Pathogenic Bacteria E. coli O157:H7: EDL 933 (ATCC 43895); a 86-24; FDIU strains; 2027; 2028; 2029; 2030; 2031; 2079; 2255; 2257; 2266; 2309; 2317; 2321; 2324; 2336; 6058 E. coli O157:H7: FDIU strains 2026 E. coli O15:H7 E. coli O15:H25 E. coli O50:H7 Salmonella newport: S. dublin; S. derby; S. enteriditis; S. enterica Typhimurium; S. cholerasuis; Enterobacter faecalis; E. faecium Non-Pathogenic Bacteria E. coli O157:H7: NCTC 12900 (ATCC 700728); b 87-23.

Techniques: